| Name | Title | Contact Details |
|---|
"Gentiva Health Services (NASDAQ: GTIV), formerly based in Melville, Long Island, New York and now in Atlanta, Georgia, is the largest provider of home health care, hospice and related services in the United States. Gentiva is a Fortune 1000 company with $1.7 billion in annual revenue. Gentiva is also a member of the S&P 600 index, developed by Standard and Poor's, featuring small capitalization U.S.-based stocks. The company offers a range of services, including nursing, physical, occupational, and speech-language therapy, cardiac and pulmonary care, disease and pain management, and other health and medical services. Gentiva provides health services to over half a million patients annuallythrough over 380 U.S. locations in 39 states. According to Morningstar, "Gentiva is a gentle giant...the nation's largest home health care services firm." Gentiva companies include Donelson, Emerald Coast, Gilbert's, Healthfield Group, Heritage, Horizon, Hospice of Charleston, Lazarus House, Tar Heel, Total Care and Wiregrass."
Freeda services the nutritional needs of the community at large as well as vegetarians/vegans, the Celiac community, Kosher consumers, Diabetics, and more...
Indiana Regional Medical Center is the only regional hospital that offers a dedicated Center for Wound Healing to help heal chronic wounds as well as Hyperbaric Oxygen Therapy for non-healing wounds.
Clarendon Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Manning, SC. To find more information about Clarendon Memorial Hospital, please visit www.clarendonhealth.com
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.